熱門資訊> 正文
Vertex Pharmaceuticals 2026年第二季度盈利预览
2026-05-09 05:35
- Vertex Pharmaceuticals (VRTX) is scheduled to announce Q2 earnings results on Monday, May 11th, after market close.
- The consensus EPS Estimate is $4.75 (+5.1% Y/Y) and the consensus Revenue Estimate is $3.22B (+8.8% Y/Y).
- Over the last 2 years, VRTX has beaten EPS estimates 50% of the time and has beaten revenue estimates 63% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 9 downward. Revenue estimates have seen 8 upward revisions and 4 downward.
- Recent earnings Analysis from our contributors:Vertex Pharmaceuticals Q1 Earnings Review: Pharma May Need Bolder M&A StrategyVertex Pharmaceuticals: Looking For Signs Of Success In Q1 Earnings
More on Vertex Pharmaceuticals
- Vertex Pharmaceuticals Q1 Earnings Review: Pharma May Need Bolder M&A Strategy
- Vertex Pharmaceuticals Incorporated 2026 Q1 - Results - Earnings Call Presentation
- Vertex Pharmaceuticals Incorporated (VRTX) Q1 2026 Earnings Call Transcript
- Vertex projects 2026 revenue of $12.95B-$13.1B while targeting $500M-plus from non-CF products
- Vertex Pharmaceuticals Non-GAAP EPS of $4.47 beats by $0.16, revenue of $2.99B misses by $10M
推薦文章
騰訊、阿里等中概巨頭業績來襲！AI收入轉化率成核心看點，這輪財報季能否助力恆科「反彈」？
港股周報 | 存儲芯片持續飆升！兩倍做多海力士周內狂漲64%；段永平重大調倉！清倉中國神華，大幅買入泡泡瑪特
一周財經日曆 | 下周重磅大事齊襲！特朗普政府或攜黃仁勛訪華；中概科網股財報季打響！騰訊、阿里同日放榜
美股機會日報 | 「TACO」已經過時？華爾街瘋狂湧入「NACHO」交易；今晚20:30！美國4月非農或創年內最大落差？
華盛早報 | 美伊突發交火！特朗普密集發聲施壓；英偉達官宣入股，IREN盤后一度暴漲27%
5月8日外盤頭條：美國計劃本周重啟護航行動 特朗普給予歐盟至7月4日批准貿易協議 OpenAI與博通芯片豪賭遇冷
CoreWeave一季度末簽約總電力容量3.5吉瓦 年內股價漲近80%
馬斯克再下注：SpaceX IPO倒計時 擬投1190億美元建Terafab芯片廠
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
